ArticleGenes & diseases2026

METTL3 promotes esophageal squamous cell carcinoma progression and reduces chemosensitivity to paclitaxel through the CASP9/BIRC3-dependent apoptosis pathway.

Pengxiang Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.